Christopher G.b. Meyer - 01 Jul 2021 Form 4 Insider Report for NET 1 UEPS TECHNOLOGIES INC (LSAK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jul 2021, 16:09:56 UTC
Next SEC filing
15 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chris G.B. Meyer

Key filing fact

Christopher G.b. Meyer filed Form 4 for NET 1 UEPS TECHNOLOGIES INC (LSAK) on 13 Jul 2021.

Key facts

  • This page summarizes Christopher G.b. Meyer's Form 4 filing for NET 1 UEPS TECHNOLOGIES INC (LSAK).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Jul 2021, 16:09.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LSAK transaction

Common Stock

Award

Transaction value
$0
Shares
+117,304
Change %
Price
$0.000000
Shares after
117,304
Date
01 Jul 2021
Ownership
Direct
Footnotes
F1
LSAK transaction

Common Stock

Award

Transaction value
$0
Shares
+58,652
Change %
+50%
Price
$0.000000
Shares after
175,956
Date
02 Jul 2021
Ownership
Direct
Footnotes
F2
LSAK transaction

Common Stock

Award

Transaction value
$0
Shares
+58,652
Change %
+33%
Price
$0.000000
Shares after
234,608
Date
02 Jul 2021
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a grant of restricted stock approved by the remuneration committee of the Issuers board of directors pursuant to the Amended and Restated 2015 Stock Incentive Plan. Vesting is subject to the recipients continuous service through the applicable vesting date on June 30, 2024.

Footnote F2

Represents a grant of restricted stock approved by the remuneration committee of the Issuers board of directors in accordance with Mr. Meyers June 30, 2021, employment agreement and pursuant to the Amended and Restated 2015 Stock Incentive Plan. Vesting is subject to the satisfaction of the following conditions: (1) the price of the Companys common stock is equal to or exceeds certain stock price levels during specific measurement period from June 30, 2021, to June 30, 2024, and (2) the recipient is employed by the Company on a full-time basis when the condition in (1) is met. If both of these conditions are not satisfied, then none of the shares of restricted stock will vest and they will be forfeited.

Footnote F3

Represents a grant of restricted stock approved by the remuneration committee of the Issuers board of directors in accordance with Mr. Meyers June 30, 2021, employment agreement and pursuant to the Amended and Restated 2015 Stock Incentive Plan. Vesting is subject to the satisfaction of the following conditions: (1) achieving the Companys three year financial services plan during the specific measurement period from June 30, 2021, to June 30, 2024, and (2) the recipient is employed by the Company on a full-time basis when the condition in (1) is met. If both of these conditions are not satisfied, then none of the shares of restricted stock will vest and they will be forfeited.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .